logologo
QuantliQuantli

ArriVent BioPharma Inc

AVBP

NASDAQ

Biotechnology

$29.51

USD

-0.49 (-1.63%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $1.44B

Volume 439.0K

Price Target

$42.00$45.00

USD

The 2 analysts offering 1-year price forecasts have a max estimate of $45.00 and a min estimate of $42.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$43.50

-$1.3 vs prior

Implied Upside

+47.4%

-4.4% vs prior

Analyst Covering

2

-3 vs prior period

Consensus

Buy

Unchanged vs prior

Signal Quality

Consensus Freshness

29%

Many ratings are older - consensus may be less current

Analyst Agreement

High

Targets are closely clustered - analysts agree more than usual

Mean vs Median

$0 Gap

Median and average are closely aligned - few outliers skewing the consensus

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

2 Buy

0 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

2

Hold

0

Sell

0

Strong Sell

0

2 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Jeet Mukherjee

BTIG

Buy

Reiterated

2 days ago

Plus
Plus
Plus

Supawat Thongthip

Truist Securities

Buy

Maintained

2 months ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

AKTS

Aktis Oncology Inc

$24.93

+4.8%

PURR

Hyperliquid Strategies Inc

$6.68

-2.0%

ORIC

Oric Pharmaceuticals Inc

$13.87

+1.1%

TYRA

Tyra Biosciences Inc

$25.29

+1.1%

ABSI

Absci Corp

$9.18

-3.0%

NVAX

Novavax Inc

$8.05

-1.1%

XNCR

Xencor Inc

$23.34

+1.5%

GLUE

Monte Rosa Therapeutics Inc

$15.50

-2.1%

JBIO

Jade Biosciences Inc

$24.71

+3.8%

VIR

Vir Biotechnology Inc

$9.24

+2.7%